WEST KELOWNA, BC--(Marketwired - February 04, 2016) - FPS PHARMA INC. ("FPS Pharma" or the "Company") advises that its securities were the subject of cease trade orders ("CTOs") issued by the British Columbia Securities Commission (the "BCSC"), Ontario Securities Commission (the "OSC") and Autorité des marchés financiers (the "AMF") issued on November 20, December 21 and December 17, 2015, respectively, for failure to file certain continuous disclosure documents including its financial statements for the period ended September 30, 2015.
The Company is pleased to report that the BCSC has revoked its CTO effective January 29, 2016 and that the AMF and OSC have revoked their CTOs effective February 2 and February 4, 2016, respectively. The Company's required filings are current as of the date of this announcement.
ON BEHALF OF THE BOARD OF DIRECTORS
"James R. Brown"
James R. Brown
Chairman, President & CEO
The Canadian Securities Exchange has neither approved nor disapproved the contents of this press release.
Contact Information:
For further information please contact:
James R. Brown
778-754-3000